KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Net Income: 2018-2025

Historic Net Income for Adaptive Biotechnologies (ADPT) over the last 8 years, with Sep 2025 value amounting to $9.5 million.

  • Adaptive Biotechnologies' Net Income rose 129.74% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year increase of 59.25%. This contributed to the annual value of -$159.6 million for FY2024, which is 29.16% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Net Income is $9.5 million, which was up 137.30% from -$25.6 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Net Income high stood at $9.5 million for Q3 2025, and its period low was -$69.5 million during Q4 2023.
  • For the 3-year period, Adaptive Biotechnologies' Net Income averaged around -$39.2 million, with its median value being -$46.2 million (2024).
  • In the last 5 years, Adaptive Biotechnologies' Net Income slumped by 72.94% in 2023 and then skyrocketed by 129.74% in 2025.
  • Quarterly analysis of 5 years shows Adaptive Biotechnologies' Net Income stood at -$61.4 million in 2021, then skyrocketed by 34.53% to -$40.2 million in 2022, then tumbled by 72.94% to -$69.5 million in 2023, then spiked by 51.46% to -$33.7 million in 2024, then spiked by 129.74% to $9.5 million in 2025.
  • Its Net Income was $9.5 million in Q3 2025, compared to -$25.6 million in Q2 2025 and -$29.8 million in Q1 2025.